(-)-epigallocatechin 3-gallate decreases expression ISO RGD:1323186 6480464 epigallocatechin gallate results in decreased expression of DAPK1 mRNA CTD PMID:12628509 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1323186 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DAPK1 mRNA CTD PMID:22079256 (-)-epigallocatechin 3-gallate increases expression ISO RGD:1323186 6480464 epigallocatechin gallate results in increased expression of DAPK1 mRNA CTD PMID:22079256 (1->4)-beta-D-glucan multiple interactions ISO RGD:1323187 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DAPK1 mRNA CTD PMID:36331819 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression EXP 6480464 o, p'-DDT results in increased expression of DAPK1 mRNA CTD PMID:22937105 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression EXP 6480464 o, p'-DDT analog results in decreased expression of DAPK1 mRNA CTD PMID:22937105 1,2-dimethylhydrazine decreases expression ISO RGD:1323187 6480464 1, 2-Dimethylhydrazine results in decreased expression of DAPK1 mRNA CTD PMID:22206623 17beta-estradiol decreases expression ISO RGD:1323186 6480464 Estradiol results in decreased expression of DAPK1 mRNA CTD PMID:16202921 , PMID:31614463 17beta-estradiol multiple interactions ISO RGD:1323186 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of DAPK1 mRNA CTD PMID:30165855 17beta-estradiol increases expression ISO RGD:1323186 6480464 Estradiol results in increased expression of DAPK1 mRNA CTD PMID:23373633 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:19576244 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1323187 6480464 [2 more ... CTD PMID:25510870 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1323186 6480464 [2 more ... CTD PMID:19022289 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO RGD:1323186 6480464 [2 more ... CTD PMID:19022289 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions EXP 6480464 [2 more ... CTD PMID:19576244 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1323186 6480464 2 more ... CTD PMID:19022289 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:19576244 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1323187 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1323187 6480464 Tetrachlorodibenzodioxin results in increased expression of DAPK1 mRNA CTD PMID:15972635 , PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of DAPK1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of DAPK1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1323187 6480464 Tetrachlorodibenzodioxin affects the expression of DAPK1 mRNA CTD PMID:21570461 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of DAPK1 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of DAPK1 mRNA CTD PMID:21346803 2-hydroxypropanoic acid decreases expression ISO RGD:1323186 6480464 Lactic Acid results in decreased expression of DAPK1 mRNA CTD PMID:30851411 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1323187 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of DAPK1 mRNA CTD PMID:20188158 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of DAPK1 mRNA CTD PMID:28522335 3-methylcholanthrene multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Methylcholanthrene] results in decreased expression of DAPK1 protein, [Diethylnitrosamine co-treated with Methylcholanthrene] results in increased methylation of DAPK1 promoter CTD PMID:20970405 3-methylcholanthrene multiple interactions ISO RGD:1323187 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of DAPK1 mRNA CTD PMID:23519560 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases methylation ISO RGD:1323186 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased methylation of DAPK1 promoter CTD PMID:15172992 4-hydroxynon-2-enal decreases expression ISO RGD:1323186 6480464 4-hydroxy-2-nonenal results in decreased expression of DAPK1 mRNA CTD PMID:12419474 4-vinylcyclohexene dioxide affects expression ISO RGD:1323187 6480464 4-vinyl-1-cyclohexene dioxide affects the expression of DAPK1 mRNA CTD PMID:20829426 5-aza-2'-deoxycytidine decreases methylation ISO RGD:1323186 6480464 Decitabine results in decreased methylation of DAPK1 promoter CTD PMID:17690560 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1323186 6480464 Decitabine inhibits the reaction [sodium arsenite results in decreased expression of DAPK1 protein] CTD PMID:19577553 5-aza-2'-deoxycytidine increases expression ISO RGD:1323186 6480464 Decitabine results in increased expression of DAPK1 mRNA CTD PMID:15924153 more ... 5-aza-2'-deoxycytidine affects expression ISO RGD:1323186 6480464 Decitabine affects the expression of DAPK1 mRNA CTD PMID:17133271 5-azacytidine affects methylation ISO RGD:1323186 6480464 Azacitidine affects the methylation of DAPK1 promoter CTD PMID:17557868 5-fluorouracil affects expression ISO RGD:1323187 6480464 Fluorouracil affects the expression of DAPK1 mRNA CTD PMID:20421339 5-fluorouracil increases expression ISO RGD:1323186 6480464 Fluorouracil results in increased expression of DAPK1 protein CTD PMID:30177839 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of DAPK1 mRNA CTD PMID:25825206 all-trans-retinoic acid increases expression ISO RGD:1323186 6480464 Tretinoin results in increased expression of DAPK1 mRNA CTD PMID:16249480 all-trans-retinoic acid decreases expression ISO RGD:1323186 6480464 Tretinoin results in decreased expression of DAPK1 mRNA CTD PMID:23724009 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of DAPK1 mRNA CTD PMID:20488242 all-trans-retinoic acid affects expression ISO RGD:1323187 6480464 Tretinoin affects the expression of DAPK1 mRNA CTD PMID:20421339 aristolochic acid A decreases expression ISO RGD:1323186 6480464 aristolochic acid I results in decreased expression of DAPK1 mRNA, aristolochic acid I results in decreased expression of DAPK1 protein CTD PMID:33212167 arsane decreases expression ISO RGD:1323186 6480464 Arsenic results in decreased expression of DAPK1 mRNA CTD PMID:23872714 arsane multiple interactions ISO RGD:1323186 6480464 [Palmitic Acid co-treated with Arsenic] affects the expression of DAPK1 mRNA, [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of DAPK1 mRNA CTD PMID:32525701 , PMID:33736254 arsane increases methylation ISO RGD:1323186 6480464 Arsenic results in increased methylation of DAPK1 promoter CTD PMID:23872714 arsenic atom decreases expression ISO RGD:1323186 6480464 Arsenic results in decreased expression of DAPK1 mRNA CTD PMID:23872714 arsenic atom multiple interactions ISO RGD:1323186 6480464 [Palmitic Acid co-treated with Arsenic] affects the expression of DAPK1 mRNA, [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of DAPK1 mRNA CTD PMID:32525701 , PMID:33736254 arsenic atom increases methylation ISO RGD:1323186 6480464 Arsenic results in increased methylation of DAPK1 promoter CTD PMID:23872714 arsenite(3-) increases methylation ISO RGD:1323186 6480464 arsenite results in increased methylation of DAPK1 promoter CTD PMID:23974009 arsenite(3-) increases expression ISO RGD:1323186 6480464 arsenite results in increased expression of DAPK1 mRNA, arsenite results in increased expression of DAPK1 protein CTD PMID:30177839 arsenite(3-) multiple interactions ISO RGD:1323186 6480464 arsenite promotes the reaction [TP53 protein binds to DAPK1 protein] more ... CTD PMID:30177839 benzo[a]pyrene decreases expression ISO RGD:1323186 6480464 Benzo(a)pyrene results in decreased expression of DAPK1 mRNA CTD PMID:20106945 , PMID:21632981 benzo[a]pyrene increases methylation ISO RGD:1323186 6480464 Benzo(a)pyrene results in increased methylation of DAPK1 5' UTR, Benzo(a)pyrene results in increased methylation of DAPK1 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1323187 6480464 Benzo(a)pyrene results in increased expression of DAPK1 mRNA CTD PMID:23735875 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1323186 6480464 7 more ... CTD PMID:19150397 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1323186 6480464 Diethylhexyl Phthalate results in increased expression of DAPK1 protein CTD PMID:31163220 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of DAPK1 mRNA CTD PMID:24066056 bisphenol A increases expression ISO RGD:1323187 6480464 bisphenol A results in increased expression of DAPK1 mRNA CTD PMID:35598803 bisphenol A multiple interactions ISO RGD:1323186 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of DAPK1 gene CTD PMID:31601247 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of DAPK1 mRNA CTD PMID:25181051 Brevetoxin B decreases expression ISO RGD:1323186 6480464 brevetoxin 2 results in decreased expression of DAPK1 mRNA CTD PMID:20498034 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of DAPK1 mRNA CTD PMID:24136188 butanal decreases expression ISO RGD:1323186 6480464 butyraldehyde results in decreased expression of DAPK1 mRNA CTD PMID:26079696 cadmium dichloride decreases expression ISO RGD:1323186 6480464 Cadmium Chloride results in decreased expression of DAPK1 mRNA CTD PMID:19426795 calcitriol decreases expression ISO RGD:1323186 6480464 Calcitriol results in decreased expression of DAPK1 mRNA CTD PMID:16002434 , PMID:21592394 calcitriol multiple interactions ISO RGD:1323186 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of DAPK1 mRNA CTD PMID:21592394 carbon nanotube decreases expression ISO RGD:1323187 6480464 Nanotubes, Carbon analog results in decreased expression of DAPK1 mRNA CTD PMID:25554681 , PMID:25620056 chelidonine affects expression ISO RGD:1323186 6480464 chelidonine affects the expression of DAPK1 mRNA CTD PMID:25265580 chloroprene increases expression ISO RGD:1323187 6480464 Chloroprene results in increased expression of DAPK1 mRNA CTD PMID:23125180 cholesterol multiple interactions EXP 6480464 6-hydroxy-2 more ... CTD PMID:19477266 cholesterol increases expression EXP 6480464 Cholesterol analog results in increased expression of DAPK1 mRNA CTD PMID:19477266 copper atom multiple interactions ISO RGD:1323186 6480464 [Chelating Agents binds to Copper] which affects the expression of DAPK1 mRNA CTD PMID:30911355 copper(0) multiple interactions ISO RGD:1323186 6480464 [Chelating Agents binds to Copper] which affects the expression of DAPK1 mRNA CTD PMID:30911355 copper(II) sulfate decreases expression ISO RGD:1323186 6480464 Copper Sulfate results in decreased expression of DAPK1 mRNA CTD PMID:19549813 coumarin increases phosphorylation ISO RGD:1323186 6480464 coumarin results in increased phosphorylation of DAPK1 protein CTD PMID:35688186 crocidolite asbestos decreases expression ISO RGD:1323186 6480464 Asbestos, Crocidolite results in decreased expression of DAPK1 mRNA CTD PMID:18687144 CU-O LINKAGE decreases expression ISO RGD:1323186 6480464 cupric oxide results in decreased expression of DAPK1 mRNA CTD PMID:22077320 cyclosporin A decreases expression ISO RGD:1323186 6480464 Cyclosporine results in decreased expression of DAPK1 mRNA CTD PMID:25562108 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of DAPK1 mRNA CTD PMID:23640034 dibutyl phthalate decreases expression ISO RGD:1323187 6480464 Dibutyl Phthalate results in decreased expression of DAPK1 mRNA CTD PMID:21266533 dichloromethane increases methylation ISO RGD:1323186 6480464 Methylene Chloride results in increased methylation of DAPK1 promoter CTD PMID:15172992 dimethylarsinous acid affects expression ISO RGD:1323186 6480464 dimethylarsinous acid affects the expression of DAPK mRNA CTD PMID:20886546 disodium selenite decreases expression ISO RGD:1323186 6480464 Sodium Selenite results in decreased expression of DAPK1 mRNA CTD PMID:16705456 , PMID:18175754 doxifluridine increases response to substance ISO RGD:1323186 6480464 DAPK1 protein results in increased susceptibility to doxifluridine CTD PMID:16734730 doxorubicin decreases expression ISO RGD:1323187 6480464 Doxorubicin results in decreased expression of DAPK1 mRNA CTD PMID:26873546 ethanol affects expression ISO RGD:1323187 6480464 Ethanol affects the expression of DAPK1 mRNA CTD PMID:30319688 ethanol affects splicing ISO RGD:1323187 6480464 Ethanol affects the splicing of DAPK1 mRNA CTD PMID:30319688 etoposide multiple interactions ISO RGD:1323186 6480464 DAPK1 protein promotes the reaction [Etoposide results in decreased expression of IKBKB protein] more ... CTD PMID:30177839 etoposide increases expression ISO RGD:1323186 6480464 Etoposide results in increased expression of DAPK1 protein, Etoposide results in increased expression of DAPK1 protein modified form CTD PMID:30177839 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of DAPK1 mRNA CTD PMID:24136188 fulvestrant multiple interactions ISO RGD:1323186 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of DAPK1 gene CTD PMID:31601247 gallic acid decreases expression ISO RGD:1323186 6480464 Gallic Acid results in decreased expression of DAPK1 mRNA CTD PMID:34408198 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of DAPK1 mRNA CTD PMID:33387578 glycine betaine decreases expression EXP 6480464 Betaine results in decreased expression of DAPK1 mRNA CTD PMID:26391144 hexadecanoic acid multiple interactions ISO RGD:1323186 6480464 [Palmitic Acid co-treated with Arsenic] affects the expression of DAPK1 mRNA CTD PMID:33736254 hydralazine decreases methylation ISO RGD:1323186 6480464 Hydralazine results in decreased methylation of DAPK1 promoter CTD PMID:15862127 hydralazine increases expression ISO RGD:1323186 6480464 Hydralazine results in increased expression of DAPK1 mRNA CTD PMID:15862127 hydrogen peroxide affects expression ISO RGD:1323186 6480464 Hydrogen Peroxide affects the expression of DAPK1 mRNA CTD PMID:20044591 hydrogen peroxide decreases expression ISO RGD:1323186 6480464 Hydrogen Peroxide results in decreased expression of DAPK1 mRNA CTD PMID:12419474 hydroxyurea increases expression ISO RGD:1323187 6480464 Hydroxyurea results in increased expression of DAPK1 mRNA CTD PMID:27208086 inulin multiple interactions ISO RGD:1323187 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of DAPK1 mRNA CTD PMID:36331819 lead diacetate increases expression ISO RGD:1323187 6480464 lead acetate results in increased expression of DAPK1 mRNA CTD PMID:21829687 lead(0) affects splicing ISO RGD:1323186 6480464 Lead affects the splicing of DAPK1 mRNA CTD PMID:28903495 lead(2+) affects splicing ISO RGD:1323186 6480464 Lead affects the splicing of DAPK1 mRNA CTD PMID:28903495 lipopolysaccharide affects expression ISO RGD:1323187 6480464 Lipopolysaccharides affects the expression of DAPK1 mRNA CTD PMID:30942577 metformin multiple interactions ISO RGD:1323186 6480464 [Paclitaxel co-treated with Metformin] results in increased expression of DAPK1 mRNA CTD PMID:29309887 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of DAPK1 mRNA CTD PMID:30467583 methidathion increases expression ISO RGD:1323187 6480464 methidathion results in increased expression of DAPK1 mRNA CTD PMID:34813904 methoxyacetic acid affects expression ISO RGD:1323187 6480464 methoxyacetic acid affects the expression of DAPK1 mRNA CTD PMID:20421339 methoxychlor affects expression ISO RGD:1323187 6480464 Methoxychlor affects the expression of DAPK1 mRNA CTD PMID:20829426 methoxychlor increases methylation EXP 6480464 Methoxychlor results in increased methylation of DAPK1 gene CTD PMID:23303685 mitomycin C increases expression ISO RGD:1323187 6480464 Mitomycin results in increased expression of DAPK1 mRNA CTD PMID:25270620 Mitotane increases expression EXP 6480464 Mitotane results in increased expression of DAPK1 mRNA CTD PMID:23485034 mitoxantrone affects response to substance ISO RGD:1323186 6480464 DAPK1 protein affects the susceptibility to Mitoxantrone CTD PMID:16217747 Monobutylphthalate affects expression ISO RGD:1323187 6480464 monobutyl phthalate affects the expression of DAPK1 mRNA CTD PMID:20421339 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of DAPK1 mRNA] CTD PMID:19477266 N-acetylsphingosine increases activity ISO RGD:1323186 6480464 N-acetylsphingosine results in increased activity of DAPK1 protein CTD PMID:17087515 N-acetylsphingosine increases activity EXP 6480464 N-acetylsphingosine results in increased activity of DAPK1 protein CTD PMID:17087515 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of DAPK1 mRNA CTD PMID:28801915 N-methyl-N-nitrosourea increases expression ISO RGD:1323187 6480464 Methylnitrosourea results in increased expression of DAPK1 mRNA CTD PMID:25270620 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Methylcholanthrene] results in decreased expression of DAPK1 protein, [Diethylnitrosamine co-treated with Methylcholanthrene] results in increased methylation of DAPK1 promoter CTD PMID:20970405 nevirapine increases expression EXP 6480464 Nevirapine metabolite results in increased expression of DAPK1 mRNA CTD PMID:23947594 nickel atom decreases expression ISO RGD:1323186 6480464 Nickel results in decreased expression of DAPK1 mRNA CTD PMID:23195993 nickel sulfate decreases expression ISO RGD:1323186 6480464 nickel sulfate results in decreased expression of DAPK1 mRNA CTD PMID:22714537 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of DAPK1 mRNA CTD PMID:24136188 Nor-9-carboxy-delta9-THC multiple interactions ISO RGD:1323186 6480464 [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of DAPK1 gene CTD PMID:30521419 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of DAPK1 mRNA CTD PMID:25729387 p-menthan-3-ol decreases expression ISO RGD:1323186 6480464 Menthol results in decreased expression of DAPK1 mRNA CTD PMID:26760959 paclitaxel multiple interactions ISO RGD:1323186 6480464 [Paclitaxel co-treated with Metformin] results in increased expression of DAPK1 mRNA CTD PMID:29309887 paracetamol multiple interactions ISO RGD:1323186 6480464 [Dietary Carbohydrates co-treated with Acetaminophen] results in increased expression of DAPK1 mRNA CTD PMID:17093179 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of DAPK1 mRNA CTD PMID:33387578 paracetamol affects expression ISO RGD:1323187 6480464 Acetaminophen affects the expression of DAPK1 mRNA CTD PMID:17562736 paraquat increases expression ISO RGD:1323186 6480464 Paraquat results in increased expression of DAPK1 mRNA CTD PMID:18836921 PCB138 multiple interactions ISO RGD:1323187 6480464 [2 more ... CTD PMID:25510870 pentanal decreases expression ISO RGD:1323186 6480464 pentanal results in decreased expression of DAPK1 mRNA CTD PMID:26079696 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1323187 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DAPK1 mRNA more ... CTD PMID:36331819 phenylephrine decreases expression EXP 6480464 Phenylephrine results in decreased expression of DAPK1 mRNA CTD PMID:18158353 phorbol 13-acetate 12-myristate increases expression ISO RGD:1323186 6480464 Tetradecanoylphorbol Acetate results in increased expression of DAPK1 mRNA CTD PMID:10910055 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1323187 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of DAPK1 mRNA CTD PMID:23519560 picoxystrobin decreases expression ISO RGD:1323186 6480464 picoxystrobin results in decreased expression of DAPK1 mRNA CTD PMID:33512557 pirinixic acid multiple interactions ISO RGD:1323186 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of DAPK1 mRNA CTD PMID:19710929 pirinixic acid multiple interactions ISO RGD:1323187 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DAPK1 mRNA CTD PMID:19710929 potassium chromate decreases expression ISO RGD:1323186 6480464 potassium chromate(VI) results in decreased expression of DAPK1 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1323186 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DAPK1 mRNA CTD PMID:22079256 quercetin decreases expression ISO RGD:1323186 6480464 Quercetin results in decreased expression of DAPK1 mRNA CTD PMID:21632981 rac-lactic acid decreases expression ISO RGD:1323186 6480464 Lactic Acid results in decreased expression of DAPK1 mRNA CTD PMID:30851411 resveratrol increases expression ISO RGD:1323186 6480464 resveratrol results in increased expression of DAPK1 mRNA, resveratrol results in increased expression of DAPK1 protein CTD PMID:23800064 resveratrol increases activity ISO RGD:1323186 6480464 resveratrol results in increased activity of DAPK1 protein CTD PMID:23800064 rotenone decreases expression ISO RGD:1323187 6480464 Rotenone results in decreased expression of DAPK1 mRNA CTD PMID:23186747 rotenone decreases expression ISO RGD:1323186 6480464 Rotenone results in decreased expression of DAPK1 mRNA CTD PMID:33512557 sodium arsenate multiple interactions ISO RGD:1323186 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of DAPK1 mRNA CTD PMID:32525701 sodium arsenite decreases expression ISO RGD:1323186 6480464 sodium arsenite results in decreased expression of DAPK1 mRNA, sodium arsenite results in decreased expression of DAPK1 protein CTD PMID:19577553 , PMID:22714537 sodium arsenite increases expression ISO RGD:1323186 6480464 sodium arsenite results in increased expression of DAPK1 mRNA CTD PMID:10910055 , PMID:24570342 sodium arsenite increases methylation ISO RGD:1323186 6480464 sodium arsenite results in increased methylation of DAPK1 promoter CTD PMID:17683884 , PMID:19577553 sodium arsenite multiple interactions ISO RGD:1323186 6480464 decitabine inhibits the reaction [sodium arsenite results in decreased expression of DAPK1 protein] more ... CTD PMID:19577553 , PMID:24570342 sodium fluoride decreases expression ISO RGD:1323187 6480464 Sodium Fluoride results in decreased expression of DAPK1 mRNA CTD PMID:27862939 Soman decreases expression EXP 6480464 Soman results in decreased expression of DAPK1 mRNA CTD PMID:19281266 streptozocin decreases expression EXP 6480464 Streptozocin results in decreased expression of DAPK1 mRNA CTD PMID:25905778 sunitinib decreases expression ISO RGD:1323186 6480464 Sunitinib results in decreased expression of DAPK1 mRNA CTD PMID:31533062 tert-butyl hydroperoxide decreases expression ISO RGD:1323186 6480464 tert-Butylhydroperoxide results in decreased expression of DAPK1 mRNA CTD PMID:12419474 , PMID:15336504 testosterone decreases expression ISO RGD:1323186 6480464 Testosterone results in decreased expression of DAPK1 mRNA CTD PMID:21592394 testosterone multiple interactions ISO RGD:1323187 6480464 1 more ... CTD PMID:33848595 testosterone increases expression ISO RGD:1323187 6480464 Testosterone deficiency results in increased expression of DAPK1 mRNA CTD PMID:33848595 testosterone multiple interactions ISO RGD:1323186 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of DAPK1 mRNA CTD PMID:21592394 tetrachloromethane decreases expression ISO RGD:1323187 6480464 Carbon Tetrachloride results in decreased expression of DAPK1 mRNA CTD PMID:27339419 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of DAPK1 mRNA CTD PMID:31150632 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of DAPK1 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1323187 6480464 titanium dioxide results in increased expression of DAPK1 mRNA CTD PMID:23557971 titanium dioxide decreases expression ISO RGD:1323187 6480464 titanium dioxide results in decreased expression of DAPK1 mRNA CTD PMID:29264374 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of DAPK1 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of DAPK1 mRNA CTD PMID:25729387 trichostatin A increases expression ISO RGD:1323186 6480464 trichostatin A results in increased expression of DAPK1 mRNA CTD PMID:16865256 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of DAPK1 mRNA CTD PMID:30589522 troglitazone decreases expression ISO RGD:1323187 6480464 troglitazone results in decreased expression of DAPK1 mRNA CTD PMID:28973697 trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of DAPK1 mRNA CTD PMID:24136188 valproic acid affects expression ISO RGD:1323187 6480464 Valproic Acid affects the expression of DAPK1 mRNA CTD PMID:20421339 valproic acid increases expression ISO RGD:1323186 6480464 Valproic Acid results in increased expression of DAPK1 mRNA CTD PMID:24383497 , PMID:24935251 valproic acid affects expression ISO RGD:1323186 6480464 Valproic Acid affects the expression of DAPK1 mRNA CTD PMID:25979313 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of DAPK1 mRNA CTD PMID:19015723 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of DAPK1 mRNA CTD PMID:23034163 vinyl carbamate increases methylation ISO RGD:1323186 6480464 vinyl carbamate results in increased methylation of DAPK1 promoter CTD PMID:15172992 vorinostat decreases expression ISO RGD:1323186 6480464 vorinostat results in decreased expression of DAPK1 mRNA CTD PMID:27188386 zoledronic acid decreases expression ISO RGD:1323186 6480464 zoledronic acid results in decreased expression of DAPK1 mRNA CTD PMID:19036117